Axsome acquires Avenue's subsidiary for epilepsy drug development
Go back to Axsome acquires Avenue's subsidiary for epilepsy drug development| (NASDAQ: ATXI) | Delayed: 0.42 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.42 | 52 Week High | $ | |||
| Open | $0.42 | 52 Week Low | $ | |||
| Day High | $0.42 | P/E | N/A | |||
| Day Low | $0.42 | EPS | $ | |||
| Volume | 27 | |||||
| (NASDAQ: AXSM) | Delayed: 238.97 +0.60 (0.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $238.37 | 52 Week High | $15.74 | |||
| Open | $239.29 | 52 Week Low | $5.37 | |||
| Day High | $242.10 | P/E | N/A | |||
| Day Low | $238.97 | EPS | $0.00 | |||
| Volume | 4,656 | |||||
| Fabien Corp (NASDAQ: FBIO) | Delayed: 3.17 -0.1 (3.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.27 | 52 Week High | $4.66 | |||
| Open | $3.26 | 52 Week Low | $2.01 | |||
| Day High | $3.26 | P/E | N/A | |||
| Day Low | $3.17 | EPS | $0.00 | |||
| Volume | 29,058 | |||||

